Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | News | August 5, 2024

Contego Medical Names Dr. Mitchell J. Silver as Chief Medical Officer

August 5, 2024—Contego Medical, Inc. announced that Mitchell J. Silver, DO, has joined the company as Chief Medical Officer (CMO). He will play a pivotal role in shaping the company’s clinical strategy and advancing the portfolio of carotid and thrombectomy products, stated the company.

Sponsored by Contego Medical, Inc.

evt | Article | November 2024 Supplement

Introduction

By Mitchell J. Silver, DO, FACC, FSVM, RPVI

Sponsored by Contego Medical

evt | Article | June 2024 Supplement

Introduction

With Mitchell J. Silver, DO, FACC, FSVM, RPVI

evt | Article | March 2003

Mechanical Devices and Acute Limb Ischemia

This increasingly common disorder responds well to alternative treatment approaches.

By Gary M. Ansel, MD; Charles F. Botti, Jr, MD; and Mitchell J. Silver, DO

Advertisement

Advertisement

evt | Article | July 2018

Acute DVT: Are We Overtreating or Undertreating?

A look at post-ATTRACT DVT care, necessary next steps, and parameters for future areas of study.

By Mitchell J. Silver, DO, FACC, FSVM, RPVI, and Michael Jolly, MD, FACC, RPVI

evt | Article | June 2009

Relative No-Stent Zones in the Femoropopliteal Arteries

Technological considerations for the infrainguinal arterial bed from one cardiology-based team.

By Gary M. Ansel, MD, FACC; Charles F. Botti Jr, MD, FACC; and Mitchell J. Silver, DO, FACC

evt | Article | February 2007

A 2007 Update on Treating Nitinol Stent Restenosis

Using Viabahn covered stents to treat restenosis in the superficial femoral artery.

By Gary M. Ansel, MD, FACC; Charles F. Botti, Jr, MD; Melinda Taylor, RN; and Mitchell J. Silver, DO

Sponsored by Contego Medical, Inc.

evt | Article | November 2024 Supplement

Embracing a New Era: Putting Data Into Practice

Dr. Silver moderates a panel of experts who discuss their experiences with the Neuroguard IEP® System, insights into the data, device design characteristics, and impact on the field.

By Mitchell J. Silver, DO, FACC, FSVM, RPVI; Gary Ansel, MD; William A. Gray, MD, MSCAI, FACC; Elad I. Levy, MD, MBA; Sean P. Lyden, MD; S. Jay Mathews, MD, FACC, FSCAI; Robert Mendes, MD, FACS; D. Christopher Metzger, MD, FACC; Kenneth Rosenfield, MD, MHCDS; Adnan H. Siddiqui, MD, PhD; and Peter A. Soukas, MD

evt | Article | October 2004

Using the Viabahn for SFA In-Stent Restenosis

The application of a covered stent to treat nitinol stent restenosis in the SFA has so far proven to be a promising approach.

By Gary M. Ansel, MD; Charles F. Botti, Jr, MD; and Mitchell J. Silver, DO

Sponsored by Inari Medical

evt | Article | July 2020

Reversing the Death Spiral: FlowTriever Thrombectomy for High-Risk PE

A panel of experts shares their high-risk PE treatment strategies and an update on the FLAME study, plus case reports of FlowTriever thrombectomy use in high-risk patients after cardiac arrest.

With James Horowitz, MD, FACC; Mitchell J. Silver, DO, FACC, FSVM, RPVI; Catalin Toma, MD; Pavan Khanna, MD; Mitchell Weinberg, MD; and Andrew Galmer, DO

evt | Article | July 2019

Panel Discussion: Putting Recent DVT Trial Data Into Context and Practice

Experts discuss the main takeaways of key trials in deep venous thrombosis therapy, nuances in their designs and data, whether the results have affected referrals, and more.

With Riyaz Bashir, MD, FACC, RVT; Rabih Chaer, MD, MSc; Rick de Graaf, MD, PhD; Mitchell J. Silver, DO, FACC, FSVM; and Brooke Spencer, MD, FSIR

Sponsored by Inari Medical

evt | Article | March 2020

Reversing the Miniaturization Trend: Why Going Bigger Is Better for Treating VTE

Design concept and case experiences—how the large-bore Triever24 catheter can extract large volumes of venous clot to optimize procedural success in different VTE settings.

With Christopher M. Huff, MD, FACC, RPVI; Michael A. Jolly, MD, FACC, RPVI; Mitchell J. Silver, DO, FACC, FSVM, RPVI; Venkat P. Tummala, MD; and Eric Trestman, MD

Sponsored by Boston Scientific Corporation

evt | Article | January 2018

Deciding DVT Treatment After ATTRACT: An Expert Panel Discussion

Leading venous interventionalists from around the globe discuss the ATTRACT results and their approach to DVT treatment.

With Stephen Black, FRCS(Ed), MD, FEBVS; Costantino Del Giudice, MD; Rick de Graaf, MD, PhD; Mark J. Garcia, MD, MS, FSIR, FACR; Nils Kucher, MD; Erin H. Murphy, MD; Marc Sapoval, MD, PhD; and Mitchell J. Silver, DO, FACC, FSVM

evt | Article | June 2009

The Ongoing SFA Evaluation

By John R. Laird Jr, MD, and Lawrence A. Garcia, MD

evt | Article | July 2019

Addressing the Unknowns of Venous Care

By Raghu Kolluri, MS, MD, RVT, FSVM, and Manjit Gohel, MD, MBChB, FRCS, FEBVS

evt | Article | February 2021

RAPID Pathways’ Approach to an Urgent Safety Signal

Discussing the challenges, opportunities, and lessons learned from paclitaxel in PAD.

By Daniel J. Bertges, MD; Mitchell W. Krucoff, MD; Aaron Lottes, PhD, MBA; Misti Malone, PhD; George Papandreou, PhD; Sara Royce, PhD; and Eleni Whatley, PhD

evt | Article | November 2010

Effects of Hypovolemia on Aortic Dimensions

Implications for endovascular repair of thoracic aortic rupture.

By Frederik H.W. Jonker, MD; Felix J.V. Schlosser, MD, PhD; Frans L. Moll, MD, PhD; Hence J.M. Verhagen, MD, PhD; and Bart E. Muhs, MD, PhD

evt | Article | January 2021

Hemodynamic Emergencies in Oncologic and Other Interventional Procedures

A review of four key hemodynamic conditions that may be encountered in interventional practice and their management.

By Tyler Munk, BSc, MBBS, FRANZCR; Jun Wang, MD, FRCPC; Ravjot Dhatt, MD, FRCPC; Anastasia Hadjivassiliou, MBBS, FRCR, FRCPC; Peter Kim, MD; Howie Lim, MD; and David M. Liu, MD, FRCPC, FSIR

Sponsored by Boston Scientific Corporation

evt | Article | September 2017 Europe Supplement

The State of Peripheral Drug‑Eluting Technologies

By Michael R. Jaff, DO


1

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button